(Q38262592)

1 September 2017

1 reference

title

Chronic kidney disease and cardiovascular complications (English)

1 reference

chronic renal insufficiency

1 September 2017

1 reference

6

Claudio Ronco

1 reference

1 September 2017

Luca Di Lullo

1

1 reference

1 September 2017

Andrew House

2

1 reference

1 September 2017

Antonio Gorini

3

1 reference

1 September 2017

Alberto Santoboni

4

1 reference

1 September 2017

Domenico Russo

5

1 reference

1 September 2017

1 May 2015

1 reference

1 September 2017

Heart Failure Reviews

1 reference

1 September 2017

20

1 reference

1 September 2017

3

1 reference

1 September 2017

259-272

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-014-9460-9

1 September 2017

0 references

cites work

The Cardiorenal Syndrome: Basis and Common Ground for a Multidisciplinary Patient-Oriented Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Defining the cause of death in hospitalised patients with acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic kidney disease and mortality risk: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Cardiovascular disease and CKD: core curriculum 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Progression of cardiac valve calcification and decline of renal function in CKD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic renal failure: a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic kidney disease: effects on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Biomarkers in kidney and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Role of angiotensin II in the altered renal function of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Accelerated renal fibrosis in cardiorenal syndrome is associated with long-term increase in urine neutrophil gelatinase-associated lipocalin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Sudden cardiac death in chronic kidney disease: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Determinants of cardiac autonomic dysfunction in ESRD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

The increasing prevalence of atrial fibrillation among hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Coronary artery disease in patients with chronic kidney disease: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Cardiac testing for coronary artery disease in potential kidney transplant recipients: a systematic review of test accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Chronic kidney disease is associated with angiographic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Mechanisms of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Coronary artery calcification and coronary flow velocity in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Pulmonary Hypertension and Right Heart Failure in Chronic Kidney Disease: New Challenge for 21st-Century Cardionephrologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Cardiovascular problems on hemodialysis: current deficits and potential improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Measurement of left ventricular mass by real-time three-dimensional echocardiography: validation against magnetic resonance and comparison with two-dimensional and m-mode measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Noninvasive imaging for assessment of calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Kidney function and progression of carotid intima-media thickness in a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Effects of age and chronic kidney disease on regional aortic distensibility: a cardiovascular magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Sudden cardiac death and dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9460-9

The prognostic importance of left ventricular geometry in uremic cardiomyopathy

21 January 2018

1 reference

12 December 2020

The clinical course of left ventricular hypertrophy in dialysis patients

1 reference

12 December 2020

Malnutrition, inflammation, and atherosclerosis in peritoneal dialysis patients

1 reference

12 December 2020

Ultrasonography: Ariadne's Thread in the Diagnosis of the Cardiorenal Syndrome.

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

12 December 2020

In-center hemodialysis six times per week versus three times per week

1 reference

12 December 2020

Influence of acute renal failure on coronary vasoregulation in dogs

1 reference

12 December 2020

1 reference

12 December 2020

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

1 reference

12 December 2020

1 reference

12 December 2020

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

12 December 2020

Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease.

1 reference

12 December 2020

Efficacy of hyperphosphatemia control in the progression of chronic renal failure and the prevalence of cardiovascular calcification.

1 reference

12 December 2020

Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance

1 reference

12 December 2020

Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study

1 reference

12 December 2020

Carotid artery Doppler ultrasonography in patients with chronic kidney disease.

1 reference

12 December 2020

Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome

1 reference

12 December 2020

Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

The normal hematocrit study--follow-up

1 reference

12 December 2020

Outcome and risk factors for left ventricular disorders in chronic uraemia

1 reference

12 December 2020

Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

1 reference

12 December 2020

Right ventricular diastolic function in dialysis patients could be affected by vascular access

1 reference

12 December 2020

Mönckeberg's medial sclerosis and inorganic phosphate in uremia.

1 reference

12 December 2020

Angiotensin II induces apoptosis of adult ventricular myocytes in vitro

1 reference

12 December 2020

10.1007/S10741-014-9460-9

Identifiers

DOI

1 reference

1 September 2017

1 reference